What is the main purpose of this 8-K filing for Johnson & Johnson?

The main purpose of this 8-K filing is to officially announce and disseminate Johnson & Johnson's sales and earnings results for the fourth quarter and the full fiscal year ended December 29, 2024, as per SEC regulations.

Where can I find the detailed financial results announced in this filing?

The detailed financial results are primarily located in Exhibit 99.1 (the press release dated January 22, 2025) and Exhibit 99.2 (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings) attached to this 8-K filing.

Does this filing provide any forward-looking guidance or commentary from JNJ management?

This 8-K filing itself, based on the provided content, primarily serves to announce past results. Detailed forward-looking guidance or management commentary is typically found within the attached press release (Exhibit 99.1) or in subsequent investor presentations, rather than within the 8-K form itself.

What does the 'Event date' and 'Filed' date signify?

The 'Event date' of January 21, 2025, likely refers to the date the results were finalized or prepared internally, while the 'Filed' date of January 21, 2025, indicates when the report was officially submitted to the SEC. The press release announcing these results was issued on January 22, 2025.

JNJ 8-K: Earnings & Results

Summary

Johnson & Johnson (JNJ) has filed an 8-K report on January 21, 2025, detailing its financial performance for the fourth quarter and full year ended December 29, 2024. The core of this filing is the press release (Exhibit 99.1) and supplementary financial data (Exhibit 99.2) which provide investors with key sales and earnings figures. While the filing itself does not contain granular operational details or forward-looking guidance, it serves as the official vehicle for disseminating the company's recently concluded fiscal period results.

Key Highlights

1Johnson & Johnson released its Q4 and Full Year 2024 financial results on January 22, 2025.
2The filing is primarily an announcement of sales and earnings figures for the period ending December 29, 2024.
3Key financial disclosures are made via an attached press release (Exhibit 99.1).
4Supplementary unaudited comparative sales data and condensed consolidated statements of earnings are also provided as Exhibit 99.2.
5This 8-K serves as notification of the official release of these financial metrics.
6Investors can access the detailed Q4 and Full Year 2024 performance data through the referenced exhibits.

JOHNSON & JOHNSON 8-K Report, Financial Results (Jan 22, 2025)

Summary

Key Highlights

Frequently Asked Questions